Page 13 - ANWITA DEVELOPMENT TO TT
P. 13
DEVELOPED & COMMERCIALISED
PRODUCT LIST (Cont.)
Active ingredients Dose or % of strength Pharmaceutical Dosage Form Therapeutic Area
AMLODIPINE BESYLATE 10MG 8.5% , 15%, 20% Capsule PPI Inhibitor
DABIGATRAN ETEXILATE 75mg, 150mg, 110mg Capsule PPI Inhibitor
TAMSULOSIN HCL 0.4MG CAPSULES Capsule
PREGABALIN 75MG CAPSULES 75mg, 150mg Capsule
DULOXETINE HCL 30MG CAPSULES 30mg, 60mg Capsule
ATENOLOL 50MG and NIFEDIPINE 20MG SR CAPSULES Capsule
CLOPIDOGREL 75MG and ASPIRIN 75 MG CAPSULES Capsule
ESOMEPRAZOLE 20MG and DOMPERIDONE 30MG SR CAPSULES Capsule
ESOMEPRAZOLE 40MG and ITOPRIDE 150MG CAPSULES Capsule
RABEPRAZOLE 20MG and ITOPRIDE 150MG CAPSULES Capsule
PANTOPRAZOLE 40MG and DOMPERIDONE 30MG SR CAPSULES Capsule
TOLTERIDONE TARTRATE 4 MG and TAMSULOSIN HCL 0.4 MG Capsule
CAPSULES
